GCC Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: Gulf states are moving beyond ad-hoc technology purchases to deliberate digital-health and AI policy implementation, which is reshaping procurement toward data-ready devices and enterprise monitoring solutions. Emirates Health Services’ stated Innovation and AI commitments (Innovation Strategy and AI Policy) are signposts that hospitals will increasingly demand devices able to integrate with national data platforms and AI workflows (EHS Innovation Strategy, Jun-2025). This structural nudge favours vendors with strong digital integration and validated AI governance.

Industry Progression: A practical market development: Emirates Health Services publicly adopted AI management best-practice guidance and began rolling policy frameworks for AI deployments (Feb-2025). The move clarified governance and accelerated pilot procurement for AI-enabled imaging and monitoring tools — a concrete signal that regional health systems will prioritise validated AI and data-interoperable devices in upcoming tenders.

Industry Player Insights: Companies including Philips Healthcare, Siemens Healthineers, GE HealthCare, and Gulf Medical Company etc. play a defining role in GCC. Industry behaviour shows the mix: Philips signed data/AI collaboration work with Abu Dhabi health authorities (MoU, Oct-2024) to trial enterprise AI performance, Siemens expanded a Riyadh regional HQ and centre of excellence (Jun-2024) to support GCC digital deployments, and Gulf Medical continues to serve as a major regional distributor — these moves accelerate AI-ready device uptake across Gulf systems.